-
EP3828179
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3828179
| EP3828179 - CYANOPYRROLIDINES AS DUB MODULATORS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 01.03.2024 Database last updated on 26.03.2026 | |
| Former | Request for examination was made Status updated on 30.04.2021 | Most recent event Tooltip | 26.02.2026 | New entry: Despatch of examination report + time limit | Applicant(s) | For all designated states Mission Therapeutics Limited Babraham Hall Babraham Cambridge CB22 3AT / GB | [2021/22] | Inventor(s) | 01 /
JONES, Alison c/o Mission Therapeutics Ltd Babraham Research Campus Moneta (Building 280) Cambridge, Cambridgeshire CB22 3AT / GB | 02 /
KEMP, Mark Ian c/o Mission Therapeutics Ltd Babraham Research Campus Moneta (Building 280) Cambridge, Cambridgeshire CB22 3AT / GB | 03 /
STOCKLEY, Martin Lee c/o Mission Therapeutics Ltd Babraham Research Campus Moneta (Building 280) Cambridge, Cambridgeshire CB22 3AT / GB | 04 /
GIBSON, Karl Richard c/o Sandexis LLP 45 Queen Street Deal Kent Deal, Kent CT14 6EY / GB | 05 /
WHITLOCK, Gavin Alistair c/o Sandexis LLP 45 Queen Street Deal Kent Deal, Kent CT14 6EY / GB | 06 /
MADIN, Andrew 8 Aster Close Bishop's Stortford, Cambridgeshire CM23 4LY / GB | [2021/22] | Representative(s) | Bridle Intellectual Property 6F Thomas Way Lakesview International Business Park Canterbury, Kent CT3 4JZ / GB | [N/P] |
| Former [2021/22] | TLIP Limited 14 King Street Leeds LS1 2HL / GB | Application number, filing date | 20162784.1 | 22.09.2015 | [2021/22] | Priority number, date | GB20140016754 | 23.09.2014 Original published format: GB 201416754 | [2021/22] | Previously filed application, date | WO2015GB52729 | 22.09.2015 | [2021/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3828179 | Date: | 02.06.2021 | Language: | EN | [2021/22] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 23.04.2021 | Classification | IPC: | C07D403/12, C07D401/12, C07D413/12, C07D417/12, C07D417/14, A61P3/00, A61P11/00, A61P25/00, A61P25/16, A61P25/28, A61P29/00, A61P31/04, A61P31/12, A61P35/00, A61P35/02, A61P43/00, A61K31/519 | [2021/22] | CPC: |
C07D417/12 (EP,CN,IL,KR,RU,US);
C07D417/14 (EP,CN,IL,KR,RU,US);
A61K31/4709 (RU);
C07D403/12 (EP,CN,IL,KR,RU,US);
A61K31/427 (KR);
A61K31/519 (EP);
A61P11/00 (EP);
A61P25/00 (EP,RU);
A61P25/16 (EP);
A61P25/28 (EP);
A61P29/00 (EP,RU);
A61P3/00 (EP,RU);
A61P31/04 (EP,RU);
A61P31/12 (EP,RU);
A61P35/00 (EP,RU);
A61P35/02 (EP);
A61P43/00 (EP);
C07D401/12 (EP,CN,IL,KR,RU,US);
C07D401/14 (EP,US);
C07D403/14 (KR);
C07D405/14 (EP,US);
C07D413/12 (EP,CN,IL,RU,US);
C07D413/14 (EP,US);
C07D471/04 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/22] | Validation states | MA | Not yet paid | Title | German: | CYANOPYRROLIDINE ALS DUB-MODULATOREN | [2021/22] | English: | CYANOPYRROLIDINES AS DUB MODULATORS | [2021/22] | French: | CYANOPYRROLIDINES COMME RÉGULATEURS DE DUB | [2021/22] | Examination procedure | 12.03.2020 | Examination requested [2021/22] | 27.08.2020 | Loss of particular rights, legal effect: Claims | 06.10.2020 | Despatch of communication of loss of particular rights: Claims {1} | 29.11.2021 | Amendment by applicant (claims and/or description) | 01.03.2024 | Despatch of a communication from the examining division (Time limit: M04) | 20.06.2024 | Reply to a communication from the examining division | 25.02.2026 | Despatch of a communication from the examining division (Time limit: M04) | Parent application(s) Tooltip | EP15774652.0 / EP3197883 | Fees paid | Renewal fee | 12.03.2020 | Renewal fee patent year 03 | 12.03.2020 | Renewal fee patent year 04 | 12.03.2020 | Renewal fee patent year 05 | 24.09.2020 | Renewal fee patent year 06 | 22.09.2021 | Renewal fee patent year 07 | 27.09.2022 | Renewal fee patent year 08 | 26.09.2023 | Renewal fee patent year 09 | 25.09.2024 | Renewal fee patent year 10 | 24.09.2025 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] WO0177073 (MERCK FROSST CANADA INC et al.) | [A] WO9508534 (GLAXO INC et al.) | [I] US2012077806 (DONATO NICHOLAS J et al.) | by applicant | WO2010059658 | WO2005089763 | WO2012174312 | CLAGUE ET AL., PHYSIOL REV, vol. 93, 2013, pages 1289 - 1315 | KIM KH ET AL., CURR PHARM DES., vol. 19, no. 22, 2013, pages 4039 - 52 | NICHOLSON B ET AL., J BIOMOL SCREEN., vol. 19, no. 7, 14 March 2014 (2014-03-14), pages 989 - 999 | RISTIC G ET AL., FRONT MOL NEUROSCI., vol. 7, 19 August 2014 (2014-08-19), pages 72 | ASHIDA H ET AL., NAT REV MICROBIOL., vol. 12, no. 6, June 2014 (2014-06-01), pages 399 - 413 | HURST-KENNEDY ET AL., BIOCHEM RES INT, 2012 | HUSSAIN ET AL., LEUKEMIA, vol. 24, 2010, pages 1641 - 1655 | BEDFORD ET AL., NATURE REV, vol. 10, 2011, pages 29 - 46 | LILLWERTZ, TRENDS IN PHARMACEUTICAL SCIENCES, vol. 35, no. 4, pages 2014 | BRYN ET AL.: "Solid-State Chemistry of Drugs", 1999, SSCI, INC OF WEST LAFAYETTE | BUNDEGAARD, H.: "Design of Prodrugs", 1985, ELSEVIER, pages: 1 - 92 |